115 related articles for article (PubMed ID: 25037345)
1. Ellagic acid encapsulated chitosan nanoparticles as anti-hemorrhagic agent.
Gopalakrishnan L; Ramana LN; Sethuraman S; Krishnan UM
Carbohydr Polym; 2014 Oct; 111():215-21. PubMed ID: 25037345
[TBL] [Abstract][Full Text] [Related]
2. Ellagic acid encapsulated chitosan nanoparticles for drug delivery system in human oral cancer cell line (KB).
Arulmozhi V; Pandian K; Mirunalini S
Colloids Surf B Biointerfaces; 2013 Oct; 110():313-20. PubMed ID: 23732810
[TBL] [Abstract][Full Text] [Related]
3. Ellagic acid-loaded, tween 80-coated, chitosan nanoparticles as a promising therapeutic approach against breast cancer: In-vitro and in-vivo study.
Kaur H; Ghosh S; Kumar P; Basu B; Nagpal K
Life Sci; 2021 Nov; 284():119927. PubMed ID: 34492262
[TBL] [Abstract][Full Text] [Related]
4. Multifunctional green synthetized gold nanoparticles/chitosan/ellagic acid self-assembly: Antioxidant, sun filter and tyrosinase-inhibitor properties.
Gubitosa J; Rizzi V; Fini P; Del Sole R; Lopedota A; Laquintana V; Denora N; Agostiano A; Cosma P
Mater Sci Eng C Mater Biol Appl; 2020 Jan; 106():110170. PubMed ID: 31753365
[TBL] [Abstract][Full Text] [Related]
5. Biodegradable in situ gelling system for subcutaneous administration of ellagic acid and ellagic acid loaded nanoparticles: evaluation of their antioxidant potential against cyclosporine induced nephrotoxicity in rats.
Sharma G; Italia JL; Sonaje K; Tikoo K; Ravi Kumar MN
J Control Release; 2007 Mar; 118(1):27-37. PubMed ID: 17258836
[TBL] [Abstract][Full Text] [Related]
6. Chitosan-Ellagic Acid Nanohybrid for Mitigating Rotenone-induced Oxidative Stress.
Ahlawat J; Neupane R; Deemer E; Sreenivasan ST; Narayan M
ACS Appl Mater Interfaces; 2020 Apr; 12(16):18964-18977. PubMed ID: 32216327
[TBL] [Abstract][Full Text] [Related]
7. Accelerating thrombolysis with chitosan-coated plasminogen activators encapsulated in poly-(lactide-co-glycolide) (PLGA) nanoparticles.
Chung TW; Wang SS; Tsai WJ
Biomaterials; 2008 Jan; 29(2):228-37. PubMed ID: 17953984
[TBL] [Abstract][Full Text] [Related]
8. Hematotoxicological analysis of surface-modified and -unmodified chitosan nanoparticles.
Nadesh R; Narayanan D; P R S; Vadakumpully S; Mony U; Koyakkutty M; Nair SV; Menon D
J Biomed Mater Res A; 2013 Oct; 101(10):2957-66. PubMed ID: 23613460
[TBL] [Abstract][Full Text] [Related]
9. Ascorbyl palmitate-loaded chitosan nanoparticles: characteristic and polyphenol oxidase inhibitory activity.
Kim MK; Lee JS; Kim KY; Lee HG
Colloids Surf B Biointerfaces; 2013 Mar; 103():391-4. PubMed ID: 23247266
[TBL] [Abstract][Full Text] [Related]
10. Alginate/chitosan nanoparticles for encapsulation and controlled release of vitamin B2.
Azevedo MA; Bourbon AI; Vicente AA; Cerqueira MA
Int J Biol Macromol; 2014 Nov; 71():141-6. PubMed ID: 24863916
[TBL] [Abstract][Full Text] [Related]
11. Glycyrrhizin conjugated chitosan nanoparticles for hepatocyte-targeted delivery of lamivudine.
Mishra D; Jain N; Rajoriya V; Jain AK
J Pharm Pharmacol; 2014 Aug; 66(8):1082-93. PubMed ID: 24641311
[TBL] [Abstract][Full Text] [Related]
12. Systemic heparin delivery by the pulmonary route using chitosan and glycol chitosan nanoparticles.
Trapani A; Di Gioia S; Ditaranto N; Cioffi N; Goycoolea FM; Carbone A; Garcia-Fuentes M; Conese M; Alonso MJ
Int J Pharm; 2013 Apr; 447(1-2):115-23. PubMed ID: 23454518
[TBL] [Abstract][Full Text] [Related]
13. Fabrication of nanoparticles using partially purified pomegranate ellagitannins and gelatin and their apoptotic effects.
Li Z; Percival SS; Bonard S; Gu L
Mol Nutr Food Res; 2011 Jul; 55(7):1096-103. PubMed ID: 21374799
[TBL] [Abstract][Full Text] [Related]
14. The evolution of clot-promoting and amidolytic activities in mixtures of Hageman factor (factor XII) and ellagic acid.
Ratnoff OD; Saito H
J Lab Clin Med; 1982 Aug; 100(2):248-60. PubMed ID: 7097109
[TBL] [Abstract][Full Text] [Related]
15. Eugenol-loaded chitosan nanoparticles: I. Thermal stability improvement of eugenol through encapsulation.
Woranuch S; Yoksan R
Carbohydr Polym; 2013 Jul; 96(2):578-85. PubMed ID: 23768603
[TBL] [Abstract][Full Text] [Related]
16. Chitosan-triphosphate nanoparticles for encapsulation of super-paramagnetic iron oxide as an MRI contrast agent.
Sanjai C; Kothan S; Gonil P; Saesoo S; Sajomsang W
Carbohydr Polym; 2014 Apr; 104():231-7. PubMed ID: 24607182
[TBL] [Abstract][Full Text] [Related]
17. Ellagic acid promoted biomimetic synthesis of shape-controlled silver nanochains.
Barnaby SN; Yu SM; Fath KR; Tsiola A; Khalpari O; Banerjee IA
Nanotechnology; 2011 Jun; 22(22):225605. PubMed ID: 21454936
[TBL] [Abstract][Full Text] [Related]
18. Development and characterization of a new plasmid delivery system based on chitosan-sodium deoxycholate nanoparticles.
Cadete A; Figueiredo L; Lopes R; Calado CC; Almeida AJ; Gonçalves LM
Eur J Pharm Sci; 2012 Mar; 45(4):451-8. PubMed ID: 21986445
[TBL] [Abstract][Full Text] [Related]
19. The inhibition of glioma growth in vitro and in vivo by a chitosan/ellagic acid composite biomaterial.
Kim S; Gaber MW; Zawaski JA; Zhang F; Richardson M; Zhang XA; Yang Y
Biomaterials; 2009 Sep; 30(27):4743-51. PubMed ID: 19501395
[TBL] [Abstract][Full Text] [Related]
20. Optimization of particle size and encapsulation efficiency of vancomycin nanoparticles by response surface methodology.
Honary S; Ebrahimi P; Hadianamrei R
Pharm Dev Technol; 2014 Dec; 19(8):987-98. PubMed ID: 24147898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
